Trials / Completed
CompletedNCT02064530
Postoperative Analgesic Effects of Dexmedetomidine for Transversus Abdominis Plane Block
Postoperative Analgesic Effects of Dexmedetomidine Added to Bupivacaine for Transversus Abdominis Plane Block for Lower Abdominal Surgery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- TC Erciyes University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
the aim of this study is evaluate postoperative analgesic effects of dexmedetomidine added to bupivacaine on TAP block in patients undergoing lower abdominal surgery.
Detailed description
TAP block is being used a method of multimodal balanced analgesia reduces postoperative pain, opioid requirement after surgery and adverse effect of opioid such as sedation, nausea vomiting and ileus. Dexmedetomidine ,an alfa-2 adrenoreceptor agonist, is being used and adjuvant capable of prolonging duration of sensory and motor block on nerve blocks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bupivacaine | 21 ml 0.5 %bupivacaine is applied interfasially |
| DRUG | Dexmedetomidine | 1 ml dexmedetomidin + 20 ml 0.5 % bupivacaine are applied interfasially |
| DRUG | serum physiologic | 21 ml serum physiologic is applied interfasially |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2014-02-17
- Last updated
- 2015-09-14
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02064530. Inclusion in this directory is not an endorsement.